Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
5-iodo A-85380 is an agonist of α4β2 and α6β2 subunit-containing nicotinic acetylcholine receptors (nAChRs).1 It activates α-conotoxin MII-sensitive and -insensitive dopamine release in rat striatal synaptosomes, markers of α4β2 and α6β2 subunit-containing nAChR activation, respectively (EC50s = 12.7 and ~35 nM, respectively). In vivo, 5-iodo A-85380 (0.37 µmol/kg per day) decreases the total number of abnormal involuntary movements (AIMs) in a rat model of L-DOPA-induced Parkinson’s disease.2
WARNING This product is not for human or veterinary use.
1. Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-
2. Nicotinic receptor agonists decrease L-